ALB and type 2 diabetes mellitus: L-4F treatment significantly decreased albumin density indicating improved BBB integrity and increased tight junction protein in the ischemic brain in both ABCA1−B/−B and ABCA1fl/fl T2DM-stroke mice measured by immunostaining (p < 0.05, n = 9/group).